Related Experiment Videos
Cardiac function in experimental uremia
Insights
Uremia increases heart contractility in animals, linked to reduced Na,K-ATPase activity and potential digitalis-like substances. Chronic uremia may cause heart failure through unknown mechanisms, despite normal contractility.
Area of Science:
- Cardiology
- Nephrology
- Biochemistry
Background:
- Uremia is associated with cardiac dysfunction, but mechanisms remain unclear.
- Acute uremia increases cardiac contractility, linked to diminished Na,K-ATPase activity and endogenous digitalis-like substances.
- Chronic uremia can lead to heart failure independent of known risk factors.
Purpose of the Study:
- To investigate the mechanisms of cardiac dysfunction in acute and chronic uremia.
- To explore the role of Na,K-ATPase activity, endogenous digitalis-like substances, and other factors in uremic cardiomyopathy.
Main Methods:
- Studies in acutely uremic animals (rats) and observations in patients with chronic uremia.
- Assessment of cardiac contractile force, sarcolemmal Na,K-ATPase activity, and levels of endogenous digitalis-like substances.
- Evaluation of cardiac response to beta-adrenergic agonists and measurement of cardiac cyclic AMP and calcium content.
Main Results:
- Acute uremia increased cardiac contractility, associated with reduced Na,K-ATPase activity and elevated endogenous digitalis-like substances.
- Impaired cardiac response to beta-adrenergic agonists was observed, with high cardiac cyclic AMP levels in acutely uremic rats.
- Heart weight increased in acutely uremic rats, unrelated to anemia, parathyroid hormone, or sympathetic activity.
Conclusions:
- Uremia induces complex cardiac abnormalities, including altered contractility and impaired response to stimuli.
- The exact mechanisms underlying uremic cardiomyopathy are multifactorial and not fully elucidated.
- Further research is needed to understand the pathogenesis of heart failure in uremia.
Abstract:
In acutely uremic animals, the contractile force of the heart is consistently increased; such an increase can be dissociated from changes of afterload or catecholaminergic drive. It is associated with diminished sarcolemmal Na,K-ATPase activity in the heart which, in turn, may be related to increased levels of endogenous digitalis-like substances (endigens) that have been postulated to represent a natriuretic factor. In patients with chronic uremia, myocardial contractility is usually normal, but occasionally there may be heart failure unrelated to pre-existing hypertension, coronary heart disease, anemia, fluid overload, or other recognizable factors. So far, the experimental basis for this clinical observation is uncertain. Possible causes for the clinical syndrome include an excess of parathyroid hormone or cardiodepressor substances. There is experimental evidence of impaired cardiac response to beta adrenergic agonists, e.g., decreased isoproterenol-dependent calcium uptake, diminished inotropic and chronotropic responses. In acutely uremic rats, cardiac cyclic AMP levels are high but can be reversed by beta blockers. Heart calcium content is variable and heart weight is constantly increased in acutely uremic rats, despite decreased skeletal muscle mass. The change in heart weight is not related to anemia, to an excess of parathyroid hormone, or to sympathetic activity; its cause remains unknown. Experimental studies to date have shown a variety of abnormalities, but do not provide a uniform concept of the mechanisms or an explanation for the cardiac dysfunction so often observed in patients with uremia.